Abel Hall LLC’s TriSalus Life Sciences TLSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-10,500
Closed -$73.3K 969
2025
Q4
$73.3K Buy
+10,500
New +$58.8K 0.02% 634

Other funds holding TLSI

Abel Hall LLC's TLSI Position: Q1 2026 in Review

Abel Hall LLC sold out of TriSalus Life Sciences (TLSI) in Q1 2026, closing a stake of 10,500 shares — an estimated $73.3K sold.

Abel Hall LLC first reported a position in TLSI in Q4 2025 and held it in 1 quarter. The position peaked at $73.3K in Q4 2025. 84 funds tracked by Wall St. Rank hold TLSI as of Q1 2026.

  • Abel Hall LLC reported no remaining TriSalus Life Sciences position as of Q1 2026 after selling out during the quarter.
  • Abel Hall LLC sold 10,500 TriSalus Life Sciences shares in Q1 2026, an estimated $73.3K.
  • Abel Hall LLC first reported a position in TriSalus Life Sciences in Q4 2025 and held it in 1 quarter.
  • Abel Hall LLC's TriSalus Life Sciences position peaked at $73.3K in Q4 2025.
  • 84 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q1 2026.

Based on Abel Hall LLC's 13F filing for Q1 2026, filed 28 Apr 2026.